ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Scientists develop method that may help treat deafness though gene therapy – Bel Marra Health

Bel Marra HealthScientists develop method that may help treat deafness though gene therapyBel Marra Healthtreat deafness though gene therapy Our ability to use our ears to hear the world around us is a vital trait that makes navigating the world around… Continue reading

2017-09-20 Michael Zand NEWS

3rd Annual Engineering Biology Award Winners Announced – Digital Journal

Continue reading

2017-09-20 Michael Zand NEWS

Guidelines address ‘unmet need’ for grading, management of CAR T cell toxicities – Healio

3rd Annual Engineering Biology Award Winners Announced
Digital Journal
The Engineering Biology Awards will recognize excellence in synthetic biology at the Mission Bay Conference Center on Oct. 4. This year’s Engineering Biology Awards winners include Harvard and MIT professor, George Church, Ph.D., MIT professor, James …

Continue reading

2017-09-20 Michael Zand NEWS

Discovery helps engineer more accurate Cas9s for CRISPR editing – UC Berkeley

UC BerkeleyDiscovery helps engineer more accurate Cas9s for CRISPR editingUC BerkeleyScientists at the University of California, Berkeley and Massachusetts General Hospital have identified a key region within the Cas9 protein that governs how accuratel… Continue reading

2017-09-20 Michael Zand NEWS

Two adorable bulldog puppies with spina bifida receive first-ever stem cell treatment initially developed for … – Daily Mail

Daily MailTwo adorable bulldog puppies with spina bifida receive first-ever stem cell treatment initially developed for …Daily MailTwo bulldog puppies with spina bifida received a stem cell treatment at UC Davis in California meaning they can now run… Continue reading

2017-09-20 Michael Zand NEWS

New Assay Leads to Step Toward Gene Therapy for Deaf Patients – The Lund Report


European Pharmaceutical Review

Guidelines address ‘unmet need’ for grading, management of CAR T cell toxicities
Healio
“CAR T cells provide an entirely new level of improved disease response among patients with certain blood cancers and hold promise for more wide-ranging use,” Elizabeth J. Shpall, MD, deputy chair and professor of stem cell transplantation and cellular …
Proposed guidelines for handling CAR T cell side effectsEuropean Pharmaceutical Review

all 2 news articles »

Continue reading

2017-09-20 Michael Zand NEWS

Lemelson, MIT give $500K to CRISPR gene editing inventor – Portland Business Journal

Portland Business JournalLemelson, MIT give $500K to CRISPR gene editing inventorPortland Business JournalZhang and his team were the first to develop and successfully demonstrate how to use the CRISPR system for editing genomes in living mouse and hum… Continue reading

2017-09-20 Michael Zand NEWS

Man beats cancer with immunotherapy and cycling – Middletown Press

New Assay Leads to Step Toward Gene Therapy for Deaf Patients
The Lund Report
CORVALLIS, Ore. – Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it. Mutations in the …

Continue reading

2017-09-20 Michael Zand NEWS
  • 1
  • …
  • 1,173
  • 1,174
  • 1,175
  • 1,176
  • 1,177
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Middletown Press

Man beats cancer with immunotherapy and cycling
Middletown Press
(AP) — Doctors told South Meriden resident Daniel Santomero he had 18 months to live in August 2015 when he was diagnosed with Stage-4 head and neck cancer. Two years later, he has beaten the odds thanks to experimental immunotherapy treatment.